Novo Nordisk
NVO
#27
Rank
โ‚น31.861 T
Marketcap
โ‚น7,256
Share price
0.41%
Change (1 day)
-27.87%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

EPS for Novo Nordisk (NVO)

EPS in 2023 (TTM): โ‚น235.77

According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is โ‚น247.44. In 2022 the company made an earnings per share (EPS) of โ‚น188.05 an increase over its 2021 EPS that were of โ‚น172.50.

EPS history for Novo Nordisk from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น235.7725.38%
2022โ‚น188.059.01%
2021โ‚น172.5015.08%
2020โ‚น149.9014.83%
2019โ‚น130.54-1.68%
2018โ‚น132.774.96%
2017โ‚น126.5031.08%
2016โ‚น96.51-10.33%
2015โ‚น107.6213.91%
2014โ‚น94.484.03%
2013โ‚น90.82-28.81%
2012โ‚น127.56108.9%
2011โ‚น61.0625.59%
2010โ‚น48.6235.01%
2009โ‚น36.01-9.17%
2008โ‚น39.6561.35%
2007โ‚น24.5728.96%
2006โ‚น19.0525.63%
2005โ‚น15.174.17%
2004โ‚น14.5613.55%
2003โ‚น12.8236.87%
2002โ‚น9.37-6.99%
2001โ‚น10.0721.56%
2000โ‚น8.2949.45%
1999โ‚น5.543.78%
1998โ‚น5.3412.15%
1997โ‚น4.7624.74%
1996โ‚น3.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น161.16-34.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น470.42 90.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น343.98 39.02%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น275.55 11.36%๐Ÿ‡ซ๐Ÿ‡ท France